INFUSYSTEM HOLDINGS, INC Share Repurchase Authorization
INFUSYSTEM HOLDINGS, INC (INFU) had Share Repurchase Authorization of $20.00 million as of 2026-05-12, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Equity
srt:StockRepurchaseProgramAuthorizedAmount1 · last filed 2026-08-04
- 2026-05-12: Stock Repurchase Program Authorized Amount1 $20.00M.
- 2024-05-16: Stock Repurchase Program Authorized Amount1 $20.00M.
| Period end | Stock Repurchase Program Authorized Amount1 |
|---|---|
| 2026-05-12 | $20.00M 10-Q · filed 2026-08-04 |
| 2024-05-16 | $20.00M 10-Q · filed 2026-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |